IBO

0.4345 +1.06%
Impact BioMedical, Inc. NYSE American Stock Pharmaceutical Stocks
Open in Risen →

Impact BioMedical, Inc. (IBO) is listed on NYSE American in the Manufacturing sector. This page tracks real-time IBO price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.

Technical Analysis

RSI (14) 42.5 Neutral
Market Cap $46.9M
Volume 20.6K

Fundamentals — 10-Q Q2 2026

Revenue $10,000
Net Income $-3.0M
EPS $-0.03
Gross Margin 90.0%
Operating Margin -29900.0%
Net Margin -29850.0%
P/E Ratio -14.5x

Recent Insider Trades

Name Title Type Shares Price Value Date
Macko Todd D Chief Financial Officer Sell 45,000 $0.56 $25,330 2026 Mar 27
Grady Jason Director Sell 50,000 $0.65 $32,505 2026 Mar 23
Dss, Inc. 10% Owner Sell 161,000 $0.55 $88,096 2025 May 27
Dss, Inc. 10% Owner Sell 890,800 $0.95 $846,260 2025 Apr 4
Chan Heng Fai Ambrose Director Sell 1,689,693 $0.66 $1.1M 2025 Apr 4
Chan Heng Fai Ambrose Director Sell 351,555 $0.50 $175,778 2025 Apr 3
Chan Heng Fai Ambrose Director Sell 2,526,918 $1.15 $2.9M 2025 Apr 1
Dss, Inc. 10% Owner Sell 605,620 $3.22 $2.0M 2025 Mar 27
Dss, Inc. 10% Owner Sell 53,100 $4.69 $249,098 2025 Mar 20
Heuszel Frank D Chief Executive Officer Buy 500 $2.26 $1,130 2024 Dec 5
Heuszel Frank D Chief Executive Officer Buy 500 $2.61 $1,305 2024 Nov 27
Heuszel Frank D Chief Executive Officer Buy 1,050 $2.61 $2,742 2024 Nov 26
Dss, Inc. 10% Owner Sell 5,700 $2.99 $17,040 2024 Nov 18
Dss, Inc. 10% Owner Buy 1,000 $2.33 $2,330 2024 Sep 18
Dss, Inc. 10% Owner Buy 57,800 $2.65 $153,220 2024 Sep 17
Barron Partners LP 10% Owner Sell 57,000 $2.50 $142,350 2007 Mar 28

Take IBO further

Set alerts on IBO

Get notified when Impact BioMedical, Inc. hits your price targets or technical conditions are met.

Get Started Free